GBI Diagnostics Inc. is a subsidiary of Beijing BGI-GBI Biotech Co., Ltd., the core subsidiary of BGI (SZSE Stock Code: 300676), which is one of the largest genomic organizations in the world with expertise in healthcare, agricultural, and environmental-related research and applications.


What We DO

  • Actively analyze and identify mutually-beneficial partnerships with companies that wish to commercialize or develop business on a global scale.

     

  • Global raw material outsourcing and procurement solutions for medical care and diagnostic device components including, but not limited to:

    • Reagents

    • Reagent Kits

    • Protein Assays

    • Biomarker Assays

    • Microfluidic Chips

  • International shipment solutions for businesses based outside the U.S. with service as an agent for importing and exporting medical care and diagnostic device instruments, equipment, and components.